Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1982 2
1991 1
1993 1
1997 1
1999 1
2018 1
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Rothmund-Thomson syndrome.
Houwing RH, Oosterkamp RF, Berghuis M, Beemer FA, Van Vloten WA. Houwing RH, et al. Among authors: oosterkamp rf. Br J Dermatol. 1991 Sep;125(3):279-80. Br J Dermatol. 1991. PMID: 1911322 No abstract available.
Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer.
Verhoeff-Jahja R, Ter Kuile MM, Weijl NI, Oosterkamp R, Cloos M, Portielje JEA, Kroep JR, Hinnen C. Verhoeff-Jahja R, et al. Among authors: oosterkamp r. Support Care Cancer. 2022 Aug;30(8):6947-6953. doi: 10.1007/s00520-022-07093-4. Epub 2022 May 11. Support Care Cancer. 2022. PMID: 35543818 Free PMC article.
[The Aicardi syndrome].
Barth PG, Oosterkamp RF, Boen-Tan TN, Valk J. Barth PG, et al. Among authors: oosterkamp rf. Tijdschr Kindergeneeskd. 1982 Apr;50(2):52-4. Tijdschr Kindergeneeskd. 1982. PMID: 6812238 Dutch. No abstract available.
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators. Bachelot T, et al. Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061. Ann Oncol. 2019. PMID: 30796821 Free article. Clinical Trial.
11 results